JP4419368B2 - プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤 - Google Patents

プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤 Download PDF

Info

Publication number
JP4419368B2
JP4419368B2 JP2002216039A JP2002216039A JP4419368B2 JP 4419368 B2 JP4419368 B2 JP 4419368B2 JP 2002216039 A JP2002216039 A JP 2002216039A JP 2002216039 A JP2002216039 A JP 2002216039A JP 4419368 B2 JP4419368 B2 JP 4419368B2
Authority
JP
Japan
Prior art keywords
general formula
group
acid
compound
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002216039A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004059439A5 (enExample
JP2004059439A (ja
Inventor
透 丸山
馨 小林
透 神戸
隆幸 丸山
秀行 吉田
昭雄 西浦
信貴 阿部
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP2002216039A priority Critical patent/JP4419368B2/ja
Publication of JP2004059439A publication Critical patent/JP2004059439A/ja
Publication of JP2004059439A5 publication Critical patent/JP2004059439A5/ja
Application granted granted Critical
Publication of JP4419368B2 publication Critical patent/JP4419368B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2002216039A 2002-07-25 2002-07-25 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤 Expired - Fee Related JP4419368B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002216039A JP4419368B2 (ja) 2002-07-25 2002-07-25 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002216039A JP4419368B2 (ja) 2002-07-25 2002-07-25 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009230262A Division JP2010006835A (ja) 2009-10-02 2009-10-02 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤

Publications (3)

Publication Number Publication Date
JP2004059439A JP2004059439A (ja) 2004-02-26
JP2004059439A5 JP2004059439A5 (enExample) 2005-09-29
JP4419368B2 true JP4419368B2 (ja) 2010-02-24

Family

ID=31937902

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002216039A Expired - Fee Related JP4419368B2 (ja) 2002-07-25 2002-07-25 プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤

Country Status (1)

Country Link
JP (1) JP4419368B2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005235309B2 (en) 2004-04-19 2012-07-26 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2009348470B2 (en) 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US11207417B2 (en) 2017-03-14 2021-12-28 Polyactiva Pty Ltd Drug-polymer conjugate
IL269321B (en) * 2017-03-14 2022-07-01 Polyactiva Pty Ltd Drug-polymer conjugation that includes a prostaglandin analog conjugated to a polytriazole polymer
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate
CN121022737A (zh) * 2025-10-30 2025-11-28 成都生基赛尔生物科技有限公司 一种脐带间充质干细胞成骨诱导分化培养基及培养方法

Also Published As

Publication number Publication date
JP2004059439A (ja) 2004-02-26

Similar Documents

Publication Publication Date Title
JP5387699B2 (ja) Ｅｐ４アゴニストを有効成分とする骨量低下疾患の治療剤
JP4547912B2 (ja) ８−アザプロスタグランジン誘導体化合物およびその化合物を有効成分として含有する薬剤
JP4596314B2 (ja) β−アラニン誘導体およびその用途
JP4582456B2 (ja) ８−アザプロスタグランジン誘導体およびその医薬用途
JP4419368B2 (ja) プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤
JPWO2006016695A1 (ja) Ｅｐ４アゴニストを含有してなる高カリウム血症の予防および／または治療剤
JP4893999B2 (ja) 吸入用医薬組成物
JP4788999B2 (ja) 分枝鎖カルボン酸化合物およびその用途
EP1609480A1 (en) Remedy for spinal canal stenosis
JP2010006835A (ja) プロスタグランジン誘導体およびその誘導体を有効成分として含有する薬剤
JP2006321737A (ja) Ｅｐ４アゴニストを含有する神経変性疾患の予防、治療および／または進展抑制剤
CN1893977B (zh) 以ep4激动剂为活性成分的治疗与骨质损失有关的疾病的药物
JP2006016318A (ja) ２−プロピルオクタン酸の脳移行性向上プロドラッグおよびその用途
JP2006016319A (ja) プロドラッグ
JP2004189659A (ja) 好中球エラスターゼ阻害剤を有効成分とする吸入剤

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050510

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050510

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070705

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081008

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081008

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081203

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090713

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091002

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20091023

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20091110

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20091123

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121211

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121211

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121211

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121211

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131211

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees